Atlas Trials

Imugene Limited

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Imugene Limited

RecordFirmDate
A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (NCT06063317)Imugene Limited2023-10-02
A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) (NCT05311176)Imugene Limited2022-08-17
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (NCT05346484)Imugene Limited2022-05-17
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer (NCT04432207)Imugene Limited2020-11-30
Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study (NCT05822427)Imugene Limited2020-08-25
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) (NCT03666000)Imugene Limited2019-03-11

Track Imugene Limited automatically

Every clearance here is in the API, with alerts when new ones post.